+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID06653816

Comparing the Exponential Injury Severity Score EISS with ISS and NISS to Predict Survival and ICU Admission in Adults with Polytrauma at Assiut University Hospitals

Led by Assiut University · Updated on 2024-12-06

250

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare three methods for assessing injury severity in patients with polytrauma, which means having multiple serious injuries in different body areas. Trauma is a leading cause of death and disability worldwide, especially among young and middle-aged people. The study focuses on evaluating a newer scoring system called the Exponential Injury Severity Score EISS against the traditional Injury Severity Score ISS and New Injury Severity Score NISS to better predict survival and intensive care needs. The study observes trauma patients admitted to Assiut University Hospitals, particularly those with multiple injuries. It analyzes how well each scoring system identifies patients at risk of death within 30 days, admission to intensive care, hospital admission on the day of injury, and emergency department readmissions within 72 hours and 30 days. No treatments or interventions are administered as it is an observational study. Participants will be monitored through hospital records and clinical data to assess outcomes such as mortality and ICU admission rates. Researchers will review the accuracy of each scoring method in predicting these outcomes. The study is open to adults aged 18 to 80 years with multiple trauma and will run until November 2025. Data collection focuses on patient injury severity and survival tracking over time.

CONDITIONS

Brief Title

Comparing Exponential Injury Severity Score (EISS) With Injury Severity Score (ISS) and New Injury Severity Score (NISS)

Research Team

M

Mohamed F Mohamed Moussa

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here